US FDA Commissioner Scott Gottlieb outlined the limitations of data from FDA's Adverse Event Reporting System (FAERS) in what may be an attempt to tamp down reactions to media and analyst reports on adverse events.
In an Oct. 2 statement, Gottlieb stressed that data associated with a particular drug or biologic do not necessarily mean...




